Skip to content

State at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
-$3.05M-25.5%

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$921.94M-51.4%
Enterprise value$3.88B-20.1%
P/S0.4×-0.3×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit.

The official record: QuidelOrtho Corporation’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's state.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's state?
QuidelOrtho Corporation (QDEL) reported state of $300K in Q4 2025.
How has QuidelOrtho Corporation's state changed year-over-year?
QuidelOrtho Corporation's state increased by 100.0% year-over-year, from $150K to $300K.
What is the long-term trend for QuidelOrtho Corporation's state?
Over 2 years (2023 to 2025), QuidelOrtho Corporation's state has grown at a -42.3% compound annual growth rate (CAGR), from -$3.6M to $1.2M.
What does state mean?
Non-cash tax impacts at the state or local level arising from timing differences between accounting and tax reporting. It indicates future tax obligations or assets that will be realized as temporary differences resolve.